Evidence map›Paper›PMID 40278294›Full record

ArticleMarine drugs2025

Rational High-Throughput System for Screening Emodin High-Yielding Mutant from Marine Strains of

Lizhi Gong, Zixuan Li, Meina Xu, Yushan Zhou, Wenqing Zhang, Jian Zhao, Xiujuan Xin, Faliang An

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Marine drugs, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lizhi GongState Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 130 Mei-Long Road, Shanghai 200237, China.
Zixuan LiState Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 130 Mei-Long Road, Shanghai 200237, China.
Meina XuCollege of Pharmacy, Jinan University, Guangzhou 510632, China.
Yushan ZhouState Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 130 Mei-Long Road, Shanghai 200237, China.
Wenqing ZhangState Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 130 Mei-Long Road, Shanghai 200237, China.
Jian ZhaoState Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 130 Mei-Long Road, Shanghai 200237, China.ORCID 0000-0003-1574-5331
Xiujuan XinState Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 130 Mei-Long Road, Shanghai 200237, China.
Faliang AnState Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 130 Mei-Long Road, Shanghai 200237, China.ORCID 0000-0002-3011-4741

Funding

National Key R&D Program of China 2018YFC1706206National Key R&D Program of China 2019YFC0312504National Natural Science Foundation of China 41876189National Natural Science Foundation of China 81703388
6 · The paper itself

Abstract

Emodin is an anthraquinone compound known for its diverse biological activities, including anti-tumor and anti-inflammatory effects, making it highly applicable in the fields of biology and medicine. The production of emodin using microorganisms represents a sustainable and environmentally friendly approach. A marine-derived

Indexed as

Aquatic OrganismsAspergillusEmodinHigh-Throughput Screening AssaysMutagenesisMutationEmodinARTPemodinhigh-throughput screeningmarine strain Aspergillus flavipes HN4-13medium optimize

Identifiers

PMID40278294
PMCPMC12028785

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.